{"id":"ethyl-eicosapentaenoic-acid","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Fish-like aftertaste"},{"rate":null,"effect":"Bleeding risk (at high doses)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"EPA-E is a purified ethyl ester form of eicosapentaenoic acid, an omega-3 fatty acid that lowers plasma triglycerides through inhibition of hepatic triglyceride synthesis and increased fatty acid oxidation. It also exerts anti-inflammatory effects by reducing production of pro-inflammatory cytokines and eicosanoids, which may benefit psychiatric and cardiovascular conditions.","oneSentence":"Ethyl eicosapentaenoic acid (EPA-E) is an omega-3 polyunsaturated fatty acid that reduces triglycerides and modulates inflammatory pathways.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:29:49.638Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder (investigational)"},{"name":"Hypertriglyceridemia (potential)"}]},"trialDetails":[{"nctId":"NCT07496515","phase":"PHASE2","title":"Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia","status":"NOT_YET_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2026-06-01","conditions":"Pediatric Chalazia","enrollment":168},{"nctId":"NCT07461649","phase":"NA","title":"Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Credit Pharmaceutical Co., Ltd.","startDate":"2026-03-15","conditions":"Bioavailability and Pharmacokinetics","enrollment":32},{"nctId":"NCT05297279","phase":"NA","title":"OMEGA - Dietary Intervention - COPD Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-01","conditions":"COPD, Chronic Obstructive Pulmonary Disease","enrollment":200},{"nctId":"NCT04485871","phase":"NA","title":"Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids","status":"RECRUITING","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2019-12-19","conditions":"Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance","enrollment":48},{"nctId":"NCT07462013","phase":"NA","title":"NUTRIBRAIN: Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice (POWER)","status":"RECRUITING","sponsor":"National Science and Technology Council, Taiwan","startDate":"2025-10-01","conditions":"Major Depressive Disorder (MDD)","enrollment":120},{"nctId":"NCT06975241","phase":"PHASE4","title":"Observing Metabolism of EPA With Consideration of Genetics And Sex","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-07-29","conditions":"Healthy, Omega 3, Metabolism, Lipids","enrollment":64},{"nctId":"NCT07439744","phase":"NA","title":"NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status","status":"RECRUITING","sponsor":"National Science and Technology Council, Taiwan","startDate":"2025-03-01","conditions":"Obese Adults, MDD","enrollment":50},{"nctId":"NCT06279793","phase":"PHASE2","title":"Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients","status":"RECRUITING","sponsor":"GCP-Service International West GmbH","startDate":"2024-02-15","conditions":"Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients","enrollment":550},{"nctId":"NCT05774665","phase":"PHASE2","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-30","conditions":"Treatment Resistant Depression, Inflammation, Overweight","enrollment":80},{"nctId":"NCT06711614","phase":"NA","title":"FIRE-Diet: Food as an Intervention to Reduce the Effects of Woodsmoke Exposure on Respiratory Health","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-06-17","conditions":"Healthy Individuals","enrollment":48},{"nctId":"NCT07394517","phase":"NA","title":"ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3","status":"NOT_YET_RECRUITING","sponsor":"Fundación del Caribe para la Investigación Biomédica","startDate":"2026-03","conditions":"Mixed Dyslipidemia","enrollment":105},{"nctId":"NCT01747447","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2012-08","conditions":"Bone Density, Body Composition, Bone Health","enrollment":771},{"nctId":"NCT07004777","phase":"NA","title":"Effect of Consuming n-3 PUFAs Rich Foods on Triglyceride Concentration and Lipoprotein Composition","status":"RECRUITING","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2026-02-01","conditions":"Hypertriglyceridemia","enrollment":375},{"nctId":"NCT01704859","phase":"NA","title":"VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2018-06-01","conditions":"Fractures","enrollment":25871},{"nctId":"NCT04573946","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2019-07-01","conditions":"Bone Density, Bone Health, Fractures","enrollment":25871},{"nctId":"NCT01653678","phase":"NA","title":"Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2011-11","conditions":"Hypertension","enrollment":25875},{"nctId":"NCT06695910","phase":"PHASE4","title":"Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).","status":"RECRUITING","sponsor":"Samuel Fortin","startDate":"2024-11-06","conditions":"Brain Fog, Cognitive Health","enrollment":48},{"nctId":"NCT01696435","phase":"NA","title":"VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Depression, Depressive Symptoms, Mood","enrollment":18353},{"nctId":"NCT01351805","phase":"NA","title":"Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Autoimmune Diseases, Systemic Inflammatory Process, Knee Pain Chronic","enrollment":25871},{"nctId":"NCT01632761","phase":"NA","title":"Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2012-11","conditions":"Anemia","enrollment":2000},{"nctId":"NCT06233825","phase":"NA","title":"Nutritional Intervention to Enhance Recovery After Arthroscopic Knee Surgery in Adults","status":"COMPLETED","sponsor":"Dr. Chris McGlory, PhD","startDate":"2024-02-01","conditions":"Anterior Cruciate Ligament Reconstruction, Muscular Atrophy","enrollment":30},{"nctId":"NCT04312932","phase":"PHASE2","title":"Fatty Acid Supplementation in Children With ASD (Study 2)","status":"COMPLETED","sponsor":"Sarah Keim","startDate":"2021-12-01","conditions":"Autism Spectrum Disorder","enrollment":98},{"nctId":"NCT06055894","phase":"NA","title":"A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-09-20","conditions":"Multiple Myeloma, Smoldering, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance","enrollment":200},{"nctId":"NCT01169259","phase":"PHASE3","title":"Vitamin D and Omega-3 Trial (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Cancer, Cardiovascular Disease","enrollment":25871},{"nctId":"NCT02178410","phase":"PHASE3","title":"VITAL Rhythm Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2012-10","conditions":"Cardiovascular Disease","enrollment":25119},{"nctId":"NCT06466278","phase":"PHASE2","title":"IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-06-01","conditions":"Aortic Valve Stenosis","enrollment":110},{"nctId":"NCT05198843","phase":"PHASE1, PHASE2","title":"Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-08","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Inflammatory Carcinoma","enrollment":1},{"nctId":"NCT06294067","phase":"PHASE1","title":"A Dose Response Investigation of Docosahexaenoic Acid (DHA)","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2024-02-26","conditions":"Nutrition, Healthy","enrollment":72},{"nctId":"NCT06494488","phase":"EARLY_PHASE1","title":"Differential Thrombogenesis by EPA and DHA Mediated by HDL","status":"RECRUITING","sponsor":"The Miriam Hospital","startDate":"2025-07-10","conditions":"Lipid Metabolism Disorders, Hypertriglyceridemia","enrollment":80},{"nctId":"NCT01624792","phase":"NA","title":"Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2011-10-25","conditions":"Chronic Obstructive Pulmonary Disease, Muscle Wasting","enrollment":64},{"nctId":"NCT01758081","phase":"NA","title":"Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)","enrollment":25874},{"nctId":"NCT04152291","phase":"NA","title":"The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism","status":"COMPLETED","sponsor":"Wihuri Research Institute","startDate":"2019-11-12","conditions":"Atherosclerosis, Low-density Lipoproteins Aggregation Susceptibility, Low-density Lipoprotein Lipid Composition","enrollment":68},{"nctId":"NCT02295059","phase":"NA","title":"Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2017-08-09","conditions":"Breast Cancer","enrollment":80},{"nctId":"NCT05007483","phase":"NA","title":"Efficacy of Diet on Quality of Life in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terry L. Wahls","startDate":"2022-02-10","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":162},{"nctId":"NCT05802797","phase":"EARLY_PHASE1","title":"Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2023-04-03","conditions":"Healthy Diet","enrollment":24},{"nctId":"NCT01442480","phase":"NA","title":"Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles","status":"COMPLETED","sponsor":"Environmental Protection Agency (EPA)","startDate":"2009-06","conditions":"Healthy","enrollment":29},{"nctId":"NCT02348073","phase":"PHASE3","title":"Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-03","conditions":"Attention Deficit Disorder With Hyperactivity, ADHD Inattention or Mixed Type, Epilepsy","enrollment":77},{"nctId":"NCT06881966","phase":"NA","title":"The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Hopital Charles Nicolle","startDate":"2025-09-01","conditions":"Rheumatoid Arthritis (RA)","enrollment":180},{"nctId":"NCT04222660","phase":"NA","title":"Corneal Nerves Function and Structure","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-06-21","conditions":"Diabetic Peripheral Neuropathy","enrollment":44},{"nctId":"NCT06738446","phase":"NA","title":"Dietary Supplementation on Tear Secretion and Inflammation in DES","status":"COMPLETED","sponsor":"Shih Chien Huang","startDate":"2021-09-27","conditions":"Dry Eye Syndrome (DES)","enrollment":52},{"nctId":"NCT04796207","phase":"NA","title":"The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2019-05-28","conditions":"Traumatic Brain Injury (TBI), Chronic Traumatic Encephalopathy (CTE)","enrollment":38},{"nctId":"NCT03428477","phase":"PHASE3","title":"EPA for Metastasis Trial 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mark A Hull, PhD FRCP","startDate":"2018-05-02","conditions":"Liver Metastasis, Colon Cancer","enrollment":418},{"nctId":"NCT06928701","phase":"NA","title":"Impact of \"Targeted\" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)","status":"RECRUITING","sponsor":"University of Eastern Piedmont","startDate":"2024-09-01","conditions":"Early Breast Cancer, Neoadjuvant Treatment","enrollment":160},{"nctId":"NCT05573672","phase":"PHASE2","title":"Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2022-08-12","conditions":"Generalized Anxiety Disorder","enrollment":50},{"nctId":"NCT02521753","phase":"NA","title":"Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients","status":"TERMINATED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2015-08","conditions":"Polycystic Ovary Syndrome, Obesity","enrollment":123},{"nctId":"NCT05379712","phase":"PHASE2","title":"Nutritional Supplementation in Head and Neck Cancers","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-10-25","conditions":"Malnourishment, Nutritional Deficiency, Undernutrition","enrollment":81},{"nctId":"NCT06154408","phase":"NA","title":"Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2022-02-10","conditions":"LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease","enrollment":102},{"nctId":"NCT03216057","phase":"NA","title":"Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.","status":"COMPLETED","sponsor":"Hospital Infantil de Mexico Federico Gomez","startDate":"2008-05-20","conditions":"Hypertriglyceridemia, Pediatric Obesity","enrollment":168},{"nctId":"NCT03313076","phase":"PHASE2","title":"Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-07-19","conditions":"Chronic Pain Following Thermal Burn Injury","enrollment":24},{"nctId":"NCT06280976","phase":"PHASE4","title":"Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2024-03-01","conditions":"Coronary Artery Disease, Atherosclerosis, Heart Attack","enrollment":""},{"nctId":"NCT06555705","phase":"NA","title":"Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-04-03","conditions":"Obesity, Childhood","enrollment":60},{"nctId":"NCT04496154","phase":"NA","title":"Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry \"Bad Cholesterol\" in the Blood","status":"COMPLETED","sponsor":"May Faraj, PDt, PhD","startDate":"2013-09-05","conditions":"Type 2 Diabetes, Insulin Sensitivity/Resistance, Inflammatory Response","enrollment":41},{"nctId":"NCT01728571","phase":"NA","title":"LungVITamin D and OmegA-3 Trial (lungVITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"COPD, Asthma, Pulmonary Function","enrollment":25871},{"nctId":"NCT05971147","phase":"NA","title":"Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation","status":"COMPLETED","sponsor":"Dr. Chris McGlory, PhD","startDate":"2023-08-01","conditions":"Skeletal Muscle Fatty Acid Metabolism","enrollment":29},{"nctId":"NCT06758778","phase":"NA","title":"CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions","status":"ENROLLING_BY_INVITATION","sponsor":"Sichuan Credit Pharmaceutical Co., Ltd.","startDate":"2025-01-03","conditions":"Bioavailability","enrollment":14},{"nctId":"NCT03576989","phase":"NA","title":"Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2019-04-15","conditions":"Chronic Venous Leg Ulcers","enrollment":296},{"nctId":"NCT06720662","phase":"NA","title":"Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-04-01","conditions":"Atherosclerosis Cardiovascular Disease","enrollment":294},{"nctId":"NCT06710080","phase":"PHASE3","title":"Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2024-12-15","conditions":"Inflammation, Community Acquired Pneumonia (CAP), Inflammation Plaque, Atherosclerotic","enrollment":168},{"nctId":"NCT04682665","phase":"","title":"Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2021-09-16","conditions":"Colon Cancer Liver Metastasis","enrollment":81},{"nctId":"NCT02719327","phase":"PHASE2, PHASE3","title":"Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2017-06-08","conditions":"Alzheimer's Disease","enrollment":131},{"nctId":"NCT03808519","phase":"NA","title":"n3 PUFA and Muscle-disuse Atrophy in Older Women","status":"TERMINATED","sponsor":"McMaster University","startDate":"2019-02-18","conditions":"Muscle Atrophy, Muscle Disuse Atrophy, Sarcopenia","enrollment":8},{"nctId":"NCT06128694","phase":"PHASE3","title":"Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients","status":"UNKNOWN","sponsor":"Kalbe International Pte. Ltd","startDate":"2023-08-01","conditions":"Malnutrition; Protein, Cancer, Lung, Cancer Cervix","enrollment":108},{"nctId":"NCT04239950","phase":"PHASE3","title":"Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia","status":"COMPLETED","sponsor":"Mochida Pharmaceutical Company, Ltd.","startDate":"2020-05-09","conditions":"Hypertriglyceridemia","enrollment":316},{"nctId":"NCT02757872","phase":"PHASE3","title":"Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2016-04","conditions":"Hypertension, Kidney Diseases","enrollment":2232},{"nctId":"NCT04216251","phase":"PHASE1, PHASE2","title":"PRevention Using EPA Against coloREctal Cancer","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2020-12-09","conditions":"Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery","enrollment":81},{"nctId":"NCT03806426","phase":"PHASE3","title":"Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis","status":"ACTIVE_NOT_RECRUITING","sponsor":"S.L.A. Pharma AG","startDate":"2018-12-05","conditions":"Familial Adenomatous Polyposis","enrollment":204},{"nctId":"NCT05763940","phase":"NA","title":"Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western University of Health Sciences","startDate":"2022-05-25","conditions":"Dry Eye Syndromes, Age-Related Macular Degeneration, Omega 3 Index","enrollment":130},{"nctId":"NCT03255187","phase":"NA","title":"Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-09-09","conditions":"Oxidative Stress, Inflammation, Blood Pressure","enrollment":70},{"nctId":"NCT04562467","phase":"PHASE4","title":"The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk","status":"COMPLETED","sponsor":"Canadian Medical and Surgical Knowledge Translation Research Group","startDate":"2020-09-24","conditions":"Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High","enrollment":70},{"nctId":"NCT06020950","phase":"NA","title":"Chia Seeds Consumption in Hypertriglyceridemia","status":"COMPLETED","sponsor":"Shahid Beheshti University","startDate":"2023-09-18","conditions":"Hypertriglyceridemia","enrollment":66},{"nctId":"NCT04268134","phase":"PHASE2","title":"Altering Lipids for Tolerance of Aromatase Inhibitor Therapy","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2020-07-28","conditions":"Breast Cancer","enrollment":77},{"nctId":"NCT05267301","phase":"PHASE4","title":"AlmegaPL CV Health Open Label Study","status":"COMPLETED","sponsor":"Qualitas Health","startDate":"2022-05-11","conditions":"Cholesterol, Triglycerides, Omega-3","enrollment":250},{"nctId":"NCT05613803","phase":"PHASE3","title":"Poly-unsaturated Fats for Improving Nasal Polyps and Asthma","status":"UNKNOWN","sponsor":"Norfolk and Norwich University Hospitals NHS Foundation Trust","startDate":"2023-10-09","conditions":"Asthma","enrollment":98},{"nctId":"NCT04897893","phase":"PHASE4","title":"Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Population Aged of 50+.","status":"COMPLETED","sponsor":"SCF Pharma","startDate":"2021-04-21","conditions":"Inflammation","enrollment":30},{"nctId":"NCT03143075","phase":"NA","title":"Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?","status":"COMPLETED","sponsor":"Region Skane","startDate":"2017-08-01","conditions":"Major Depressive Disorder","enrollment":95},{"nctId":"NCT06129526","phase":"PHASE4","title":"Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes","status":"UNKNOWN","sponsor":"University of Ioannina","startDate":"2023-12","conditions":"Diabetes Type 2, Hypertriglyceridemia, Diabetes Mellitus","enrollment":450},{"nctId":"NCT05457023","phase":"","title":"Plasma Neurofilament Light and Its Relationship With Omega-3 Status and Soccer Heading in Women Soccer Players","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2022-07-28","conditions":"Brain Trauma","enrollment":27},{"nctId":"NCT05491759","phase":"PHASE4","title":"A Study to Determine Optimal Absorption of Single Dose Omega-3","status":"COMPLETED","sponsor":"RDC Clinical Pty Ltd","startDate":"2022-08-04","conditions":"Optimal Gastrointestinal Absorption of Omega-3","enrollment":22},{"nctId":"NCT04495816","phase":"PHASE2","title":"COVID-19 Anosmia Study","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2020-07-15","conditions":"Anosmia, Covid19","enrollment":139},{"nctId":"NCT03670875","phase":"NA","title":"Non-Pharmacologic Alternatives for Childhood Obesity","status":"COMPLETED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2021-07-31","conditions":"Obesity in Childhood","enrollment":300},{"nctId":"NCT05394701","phase":"NA","title":"Comparing the Pharmacological Profile of Formulations Containing Omega 3 Fatty Acids","status":"COMPLETED","sponsor":"Factors Group of Nutritional Companies Inc.","startDate":"2022-03-01","conditions":"Pharmacokinetics","enrollment":12},{"nctId":"NCT02617511","phase":"NA","title":"Omega-3 Supplementation and Resistance Training","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2015-10","conditions":"Sarcopenia, Dynapenia, Inflammation","enrollment":24},{"nctId":"NCT01078909","phase":"PHASE3","title":"Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation","status":"COMPLETED","sponsor":"Penn State University","startDate":"2011-10","conditions":"Cardiovascular Disease, Inflammation","enrollment":125},{"nctId":"NCT01782352","phase":"NA","title":"Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Age-related Macular Degeneration","enrollment":25871},{"nctId":"NCT05955248","phase":"NA","title":"Multimodal Prehabilitation for Lung Cancer Surgery","status":"UNKNOWN","sponsor":"Stéphanie Chevalier","startDate":"2023-06-26","conditions":"Lung Cancer, Surgery","enrollment":168},{"nctId":"NCT04505098","phase":"PHASE4","title":"A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults","status":"TERMINATED","sponsor":"Kaiser Permanente","startDate":"2020-08-07","conditions":"Covid19, Atherosclerosis, Cardiovascular Diseases","enrollment":39600},{"nctId":"NCT05847608","phase":"NA","title":"Omega-3 Treatment for Concussion in Adolescents","status":"UNKNOWN","sponsor":"University of Manitoba","startDate":"2023-06","conditions":"Concussion, Mild","enrollment":140},{"nctId":"NCT04844034","phase":"NA","title":"Effects of a High EPA Multinutrient Supplement on Negative Affect in Young Adults.","status":"UNKNOWN","sponsor":"University of Roehampton","startDate":"2022-04-19","conditions":"Anxiety, Depression","enrollment":94},{"nctId":"NCT01633177","phase":"NA","title":"Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2010-09","conditions":"Type 2 Diabetes","enrollment":25875},{"nctId":"NCT05533658","phase":"NA","title":"The Effects of VisionPure™ on Indices of Vision Health and Cognitive Function","status":"COMPLETED","sponsor":"Applied Science & Performance Institute","startDate":"2022-08-01","conditions":"Eye Health, Vision, Cognitive Function","enrollment":15},{"nctId":"NCT04198805","phase":"PHASE2","title":"Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)","status":"COMPLETED","sponsor":"Naga P. Chalasani","startDate":"2020-01-03","conditions":"Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Fatty Liver, Non-Alcoholic Steatohepatitis","enrollment":205},{"nctId":"NCT05796401","phase":"PHASE3","title":"Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2023-06-15","conditions":"Psychosis","enrollment":500},{"nctId":"NCT05825976","phase":"NA","title":"Omega-3 Fatty Acid Supplementation and Tear Film Quality in Celiac Patients","status":"UNKNOWN","sponsor":"Josip Juraj Strossmayer University of Osijek","startDate":"2023-03-25","conditions":"Dry Eye Syndromes, Celiac Disease","enrollment":45},{"nctId":"NCT01669915","phase":"NA","title":"A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2011-09-14","conditions":"Cognitive Decline","enrollment":3424},{"nctId":"NCT03167307","phase":"PHASE3","title":"The Omega-3 Fatty Acid Paediatric Depression Trial","status":"COMPLETED","sponsor":"Gregor Berger","startDate":"2017-04-28","conditions":"Depression","enrollment":257},{"nctId":"NCT05271591","phase":"","title":"Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA)","status":"COMPLETED","sponsor":"Canadian Medical and Surgical Knowledge Translation Research Group","startDate":"2022-03-05","conditions":"Cardiovascular Diseases, Atherosclerotic Cardiovascular Disease, Myocardial Infarction","enrollment":200},{"nctId":"NCT03443076","phase":"NA","title":"Bioavailability of EPA + DHA in a SMEDS Formulation","status":"COMPLETED","sponsor":"Midwest Center for Metabolic and Cardiovascular Research","startDate":"2018-02-16","conditions":"Bioavailability","enrollment":24},{"nctId":"NCT04570995","phase":"NA","title":"Effect of Fish Oil on Athlete's Executive Function","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2020-11-05","conditions":"Brain Health, Brain Function, Brain Development","enrollment":22},{"nctId":"NCT02926027","phase":"PHASE4","title":"Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2017-03-28","conditions":"Hypertriglyceridemia","enrollment":80},{"nctId":"NCT02597439","phase":"PHASE4","title":"Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe","status":"COMPLETED","sponsor":"Rene Kahn","startDate":"2016-09-30","conditions":"Ultra High Risk for Psychosis","enrollment":145}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ethyl EPA; icosapent ethyl"],"phase":"marketed","status":"active","brandName":"Ethyl Eicosapentaenoic Acid","genericName":"Ethyl Eicosapentaenoic Acid","companyName":"New York State Psychiatric Institute","companyId":"new-york-state-psychiatric-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethyl eicosapentaenoic acid (EPA-E) is an omega-3 polyunsaturated fatty acid that reduces triglycerides and modulates inflammatory pathways. Used for Major depressive disorder (investigational), Hypertriglyceridemia (potential).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}